Cagrilintide , developed by , is an analog of amylin, a hormone co-secreted with insulin that slows gastric emptying and promotes satiety
Symptoms may include fever or chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, and diarrhea
During this period, the FDA added tirzepatide to its drug shortage list and worked with the manufacturer to increase production
Sitagliptin/Metformin 50 mg/850 mg film-coated tablets Patient Information Leaflet
Most are mild to moderate and improve as your body adjusts to the medication
Common options include GLP-1 injections, GLP-1 injection therapies, and semaglutide injections, all of which deliver the active ingredient through a simple injection schedule